Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Intangibles: 2017-2024

Historic Intangibles for Adma Biologics (ADMA) over the last 7 years, with Dec 2024 value amounting to $460,000.

  • Adma Biologics' Intangibles fell 91.18% to $491,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $491,000, marking a year-over-year decrease of 91.18%. This contributed to the annual value of $460,000 for FY2024, which is 91.18% down from last year.
  • Per Adma Biologics' latest filing, its Intangibles stood at $460,000 for FY2024, which was down 91.18% from $5.2 million recorded in FY2023.
  • Adma Biologics' 5-year Intangibles high stood at $5.2 million for FY2023, and its period low was $460,000 during FY2024.
  • Over the past 3 years, Adma Biologics' median Intangibles value was $5.0 million (recorded in 2022), while the average stood at $3.6 million.
  • As far as peak fluctuations go, Adma Biologics' Intangibles increased by 4.19% in 2023, and later crashed by 91.18% in 2024.
  • Over the past 5 years, Adma Biologics' Intangibles (Yearly) stood at $5.0 million in 2020, then remained steady at $5.0 million in 2021, then declined by 0.01% to $5.0 million in 2022, then grew by 4.19% to $5.2 million in 2023, then plummeted by 91.18% to $460,000 in 2024.